Definium Therapeutics Earnings
NASDAQ: DFTXHealth Care Medicinal Chemicals and Botanical Products USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Nov 5, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.54
Definium Therapeutics earnings summary
Definium Therapeutics is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $-0.54. In its most recent report on Aug 6, 2026 (Q2 2026), DFTX posted EPS of $-1.44. Across the last 16 reports, DFTX shares moved an average of 10.6% (in either direction) in the first trading session after results, rising 4 times and falling 12 times.
Summary generated from market data by MetaCap's automated system. Methodology
DFTX earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 6, 2026 | — | $-1.44 | — | -7.6% |
| May 7, 2026 | — | $-0.71 | — | -4.8% |
| Feb 26, 2026 | — | $-0.43 | — | +1.2% |
| Nov 6, 2025 | — | $-0.78 | — | -3.0% |
| Jul 31, 2025 | — | $-0.50 | — | +16.7% |
| May 8, 2025 | — | $-0.35 | — | +7.3% |
| Mar 6, 2025 | — | $0.13 | — | -7.0% |
| Nov 7, 2024 | — | $-0.27 | — | -8.6% |
| Aug 13, 2024 | — | $-0.26 | — | -5.3% |
| May 8, 2024 | — | $-1.14 | — | -11.2% |
| Feb 28, 2024 | — | $-0.58 | — | +55.7% |
| Nov 2, 2023 | — | $-0.45 | — | -19.1% |
| Aug 3, 2023 | — | $-0.76 | — | -2.1% |
| May 4, 2023 | — | $-0.65 | — | -10.3% |
| Mar 9, 2023 | — | $-0.02 | — | -3.7% |
| Nov 10, 2022 | — | $-0.56 | — | -6.2% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.